ATRIAL FIBRILLATION TREATMENT News, Sports, Shopping, Travel information

Looking for Atrial Fibrillation?
Find Top Rated Atrial Fibrillation Listings! Save Time and Money. Check the site for Atrial Fibrillation
netshoppers.com

Lessening Medication For Atrial Fibrillation Does Not Reduce Side ... - Physorg
reducing how often a patient receives amiodarone, a medication used for suppressing atrial fibrillation (irregular heart beat) but which causes side effects, did not decrease the overall amount of amiodarone-related and heart disease related side ...
www.physorg.com

Warfarin Underused In Atrial Fibrillation Patients
tuesday, oct. 14 (healthday news) -- a new study reports that warfarin, a common treatment for atrial fibrillation, is either not prescribed by u.s. doctors as often as it could be or, when it is, not at optimal therapeutic doses.
news.yahoo.com

Lessening Medication For Atrial Fibrillation Does Not Reduce Side Effects
reducing how often a patient receives amiodarone, a medication used for suppressing atrial fibrillation (irregular heart beat) but which causes side effects, did not decrease the overall amount of amiodarone-related and heart disease related side effects, but did increase the rate of atrial fibrillation recurrence and the risk of death from all causes and cardiovascular hospitalizations, ...
www.newswise.com

Warfarin Underused In Atrial Fibrillation Patients - Forbes
tuesday, oct. 14 (healthday news) -- a new study reports that warfarin, a common treatment for atrial fibrillation, is either not prescribed by u.s. doctors as often as it could be or, when it is, not at optimal therapeutic doses. more than 2 million ...
www.forbes.com

Taking Cordarone For Short Time Not An Option - Reuters
london (reuters) - taking the wyeth heart drug cordarone for shorter periods of time did little to ease side effects and left patients with a higher risk of premature death than those taking it for long periods, dutch researchers said on tuesday ...
www.reuters.com

Lessening Medication For Atrial Fibrillation Does Not Reduce Side Effects
( jama and archives journals ) reducing how often a patient receives amiodarone, a medication used for suppressing atrial fibrillation (irregular heart beat) but which causes side effects, did not decrease the overall amount of amiodarone-related and heart disease related side effects, but did increase the rate of atrial fibrillation recurrence and the risk of death from all causes and ...
www.eurekalert.org

St. Jude Medical Announces European Ce Mark Approval Of Implantable Device For The Detection Of Atrial Fibrillation ...
st. jude medical, inc. (nyse:stj) today announced it has received approval for european ce marking of its sjm confirm(tm) implantable cardiac monitor (icm), a compact device designed to detect atrial fibrillation (af) and other abnormal heart rhythms.
www.centredaily.com

Taking Cordarone For Short Time Not An Option -study - Reuters
london, oct 14 (reuters) - taking the wyeth (wye.n: quote , profile , research , stock buzz ) heart drug cordarone for shorter periods of time did little to ease side effects and left patients with a higher risk of premature death than those taking ...
www.reuters.com

Predicting Success Of Treatment For Atrial Fibrillation Aided By Novel ... - Medical News Today
university of utah researchers have developed a magnetic resonance imaging (mri)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation. the ...
www.medicalnewstoday.com

Warfarin Underused In Atrial Fibrillation Patients
study says blood thinner not prescribed often enough, but notes it's hard to manage.
www.healthcentral.com

Predicting Success Of Treatment For Atrial Fibrillation Aided By Novel Imaging Approach
university of utah researchers have developed a magnetic resonance imaging (mri)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation. the results of the study are published in the oct. 7, 2008, issue of the journal of the american college of cardiology.
www.medicalnewstoday.com

Texas Cardiac Arrhythmia Institute At St. David's Medical Center ... - Yahoo Finance
austin, texas, oct. 7 /prnewswire/ -- the texas cardiac arrhythmia institute (tcai) at st. david's medical center has been selected as one of only a few sites in the nation to participate in an fda-approved clinical trial for a new device to treat ...
biz.yahoo.com

Cardima Appoints Japan Lifeline As Its Distribution Partner In Japan ... - Msn Moneycentral
cardima, inc. (otcbb: cadm), a medical device company focused on the treatment of atrial fibrillation ("af") and manufacturer of the cardima surgical ablation system, the ep ablation system, and the pathfinder® family of diagnostic microcatheters ...
news.moneycentral.msn.com

Taking Cordarone For Short Time Not An Option
taking the wyeth heart drug cordarone for shorter periods of time did little to ease side effects and left patients with a higher risk of premature death than those taking it for long periods, dutch researchers said on tuesday.
news.yahoo.com

Toccata Clinical Study - Multi-center European Safety Study On Groundbreaking Technology For The Treatment Of Atrial ...
endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the toccata (touch+ for catheter ablation) clinical study to evaluate the safety of the tacticath™ system with enrollment gaining momentum. toccata is a 70 patient european multi-center safety study.
www.medicalnewstoday.com

Endosense Initiates Atrial Arrhythmias Study - Pharmaceutical Business Review
toccata is a 70 patient european multi-center safety study. constructed to gain the ce mark for the treatment of atrial arrhythmias, secondary endpoints were designed to evaluate the value of force-sensing in successfully impacting outcomes of the ...
www.pharmaceutical-business-review.com

St. Jude Medical Announces European Ce Mark Approval Of Implantable ... - Genetic Engineering News
st. jude medical, inc. ( nyse:stj ) today announced it has received approval for european ce marking of its sjm confirm(tm) implantable cardiac monitor (icm), a compact device designed to detect atrial fibrillation (af) and other abnormal heart ...
www.genengnews.com

Focus Stock: St. Jude Medical Picks Up The Pace

www.businessweek.com

St. Jude Medical Gets Approvals For Angio-seal, Cardiac Monitor
st. jude medical inc. won approvals on both sides of the atlantic for a pair of new products. (stj)
www.bizjournals.com

Toccata Clinical Study - Multi-center European Safety Study On ... - Medical News Today
endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the toccata (touch+ for catheter ablation) clinical study to evaluate the safety of the ...
www.medicalnewstoday.com